Ep. 144: “Atypical T Cell Lineages” Featuring Dr. Dan Littman
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Dr. Dan Littman is a Professor at the NYU Grossman School of Medicine. He discusses how his lab investigates the molecular mechanisms that regulate T cell development and differentiation, including the role of RORγt in shaping immune cell identity and function. He also explores the discovery of unconventional antigen-presenting cells involved in immune tolerance, how the gut microbiome influences T cell responses and cancer immunotherapy, and the potential of emerging technologies to uncover the complex interactions between microbes and the immune system.
Featured Products and Resources:- Scale up your cell isolation and process large-volume samples with the new Easy 250 EasySep Magnet.
- Stay current with the latest news, research, policy, and jobs in the immunology community with Immune Regulations News.
Sugar Disrupts the Microbiome – High sugar intake during antibiotic treatment worsens gut microbiome disruption and promotes Enterococcus expansion.
Diet Shapes Immunotherapy Toxicity – Diet and gut microbiota influence immunotherapy side effects, revealing potential ways to reduce inflammation.
Tregs Support Intestinal Recovery – Intestinal epithelial NF-κB signaling recruits regulatory T cells to promote inflammation resolution and tissue repair.
PPARδ Boosts Anti-Tumor Immunity – Activating PPARδ enhances T cell metabolism and anti-tumor activity, improving immunotherapy responses in preclinical models.
Image courtesy of Dr. Dan Littman
Subscribe to our newsletter!Never miss updates about new episodes.
Subscribe